as on March 7, 2026 at 7:53 am IST
Day's Low
Day's High
3.51%
Downside
5.85%
Upside
52 Week's Low
52 Week's High
16.96%
Downside
1207.60%
Upside
Check Silexion Therapeutics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$5.8M
EPS (TTM)
-6.035
Dividend Yield
0.00%
PE Ratio (TTM)
0.01
Industry PE ratio
0PEG Ratio
0Return On Equity TTM
-771.23%
Track how Silexion Therapeutics Corp P/E has moved over time to understand its valuation trends.
Silexion Therapeutics Corp in the last 5 years
Lowest (-0.55x)
September 30, 2024
Industry (0.00x)
March 9, 2026
Today (0.01x)
March 9, 2026
Highest (-0.02x)
June 30, 2025
Today’s Price to Earnings Ratio: 0.01x
Compare market cap, revenue, PE, and other key metrics of Silexion Therapeutics Corp with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $5.8M | NA | 0.01 | 0.00% | |
| BUY | $42.5B | 132.9% | 137.03 | 8.45% | |
| BUY | $116.0B | 113.37% | 29.85 | 32.94% | |
| NA | $33.3B | NA | 590.43 | 5.37% | |
| BUY | $80.3B | 61.46% | 18.31 | 31.41% |
The Silexion Therapeutics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Silexion Therapeutics Corp investment value today
Current value as on today
₹13,850
Returns
Returns from Silexion Therapeutics Corp Stock
Dollar Returns*
₹5,278 (+5.28%)
Search interest for Silexion Therapeutics Corp Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 31.1% return, outperforming this stock by 122.4%
Price Dip
![]()
In the last 3 months, SLXN stock has moved down by -43.5%
| Organisation | Silexion Therapeutics Corp |
| Headquarters | The Goldyne Savad Inst. of Gene Therapy, Jerusalem, Israel, 9112001 |
| CEO | Mr. Ilan Hadar M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Ilan Hadar M.B.A. | Chairman & CEO |
Ms. Mirit Horenshtein Hadar | EVP of Finance Affairs, CFO & Secretary |
Dr. Mitchell Shirvan M.B.A., Ph.D. | Chief Scientific & Development Officer |
Silexion Therapeutics Corp share price today is $1.71 as on at the close of the market. Silexion Therapeutics Corp share today touched a day high of $1.81 and a low of $1.65.
Silexion Therapeutics Corp share touched a 52 week high of $22.36 on and a 52 week low of $1.42 on . Silexion Therapeutics Corp stock price today i.e. is closed at $1.71,which is 92.35% down from its 52 week high and 20.42% up from its 52 week low.
Silexion Therapeutics Corp market capitalisation is $0.00T as on .
Indian investors can start investing in Silexion Therapeutics Corp (SLXN) shares with as little as ₹91.908 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹919.08 in Silexion Therapeutics Corp stock (as per the Rupee-Dollar exchange rate as on ).
Based on Silexion Therapeutics Corp share’s latest price of $1.71 as on March 7, 2026 at 2:23 am IST, you will get 5.8480 shares of Silexion Therapeutics Corp. Learn more about
fractional shares .